Grace Therapeutics, Inc. (GRCE) — Cash Flow Reinvestment Rate
Latest as of December 2012:
0.59x
Grace Therapeutics, Inc. (GRCE) has a Cash Flow Reinvestment Rate of 0.59x as of December 2012, reinvesting $80.55K (capex $80.55K ) from operating cash flow of $136.29K. Check GRCE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.59x
(Capex + Investments) / Operating CF
Total Reinvested
$80.55K
Capex + Investments
Operating Cash Flow
$136.29K
USD
Capital Expenditures
$80.55K
USD
Annual Cash Flow Reinvestment Rate for Grace Therapeutics, Inc. (None–None)
Year-by-year capital reinvestment analysis for Grace Therapeutics, Inc.. For live market cap and broader valuation context, see Grace Therapeutics, Inc. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow